Wanbangde Pharmaceutical Holding Group Co., Ltd. (SHE:002082)

SHE:002082 Revenue

Wanbangde Pharmaceutical Holding Group had revenue of 374.21M CNY in the quarter ending March 31, 2026, with 18.76% growth. This brings the company's revenue in the last twelve months to 1.18B, down -11.50% year-over-year. In the year 2025, Wanbangde Pharmaceutical Holding Group had annual revenue of 1.12B, down -22.59%.

• Revenue (ttm): 1.18B
• Revenue Growth: -11.50%
• P/S Ratio: 6.03
• Revenue / Employee: 872.72K
• Employees: 1,348
• Market Cap: 7.09B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	1.12B	-326.04M	-22.59%
Dec 31, 2024	1.44B	-98.57M	-6.39%
Dec 31, 2023	1.54B	-244.49M	-13.69%
Jan 1, 2023	1.79B	-144.17M	-7.47%
Jan 1, 2022	1.93B	-11.77B	-85.91%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jun 30, 2026

Data Sources Report a data error